The largest database of trusted experimental protocols

Luna c18 column

Manufactured by Phenomenex
Sourced in United States, Japan, Germany, Italy, United Kingdom, France

The Luna C18 column is a high-performance liquid chromatography (HPLC) column designed for the separation and analysis of a wide range of organic compounds. The column features a silica-based stationary phase with chemically bonded C18 alkyl chains, which provides enhanced selectivity and retention for non-polar analytes. The Luna C18 column is suitable for a variety of applications, including drug analysis, environmental monitoring, and food chemistry.

Automatically generated - may contain errors

553 protocols using luna c18 column

1

Analytical RP-HPLC Purification of Crude Products

Check if the same lab product or an alternative is used in the 5 most similar protocols
Analytical RP-HPLC was performed on a KNAUER
(H. Knauer, Bad Homburg,
Germany) system using a Phenomenex Luna C18 column (250 mm ×
4.6 mm) with 5 μm silica (100 Å pore size) (Torrance, CA)
as a stationary phase. A linear gradient elution (0 min 0% B; 5 min
0% B; 50 min 90% B) with eluent A (0.1% TFA in water) and eluent B
[0.1% TFA in acetonitrile–water (80:20, v/v)] was used at a
flow rate of 1 mL/min. Peaks were detected at λ = 220 nm. The
crude products were purified on a preparative Phenomenex Luna C18
column (250 mm × 21.2 mm) with 10 μm silica (100 Å
pore size). An isocratic elution with 5% of eluent B (using the same
eluents) was applied from 0 to 5 min; then, from 5 to 50 min, a gradient
elution of 5–50% of eluent B was used with a 9 mL/min flow
rate. Peaks were detected at λ = 220 nm.
+ Open protocol
+ Expand
2

Isolation and Characterization of Bioactive Metabolites

Check if the same lab product or an alternative is used in the 5 most similar protocols
The crude MeOH extract (10.9 g) was found to inhibit collagen induction and E-cadherin down-regulation. Extensive LC/MS analysis of the MeOH extract in our LC/MS system showed non-polar metabolite peaks exhibiting strong UV absorption at around 200–220 nm, with interesting ion peaks at m/z 439 and 515, which suggested the possibility of the presence of peptidic-type metabolites. The MeOH extract was dissolved in distilled water (700 mL) and solvent-partitioned with EtOAc (700 mL × 3) to yield the EtOAc-soluble fraction (1.1 g). The EtOAc-soluble fraction, which contained promising peaks on LC/MS analysis, was loaded onto a silica gel (230–400 mesh) column chromatography and fractionated with a gradient solvent system of CH2Cl2-MeOH (50:1–1:1, v/v) to afford seven subfractions (B1–B7). Subfraction B3 (36.5 mg) was isolated by semi-preparative reversed-phase HPLC (Phenomenex Luna C-18 column, 250 × 10.0 mm, 5 μm) eluted with 73% MeOH/H2O (flow rate: 2 mL/min) to obtain compounds 3 (2.6 mg, tR = 45.0 min) and 4 (2.7 mg, tR = 48.0 min). Subfraction B4 (20.4 mg) was purified to acquire compounds 1 (2.7 mg, tR = 41.0 min) and 2 (1.6 mg, tR = 44.5 min) by semi-preparative reversed-phase HPLC (Phenomenex Luna C-18 column, 250 × 10.0 mm, 5 μm) with 70% MeOH/H2O (flow rate: 2 mL/min).
+ Open protocol
+ Expand
3

Radiolabeling of Precursor 33 with [11C]Iodomethane

Check if the same lab product or an alternative is used in the 5 most similar protocols
Precursor 33 (0.7 mg, 2.3 μmol) was dissolved in DMF (80 μL). Tetra-n-butylammonium hydroxide (TBAH) in MeOH (0.5 M, 4.0 μL) was added to this solution and then injected into the loop of an AutoLoop apparatus (Bioscan; Washington, DC). [11C]Iodomethane was released from the PETtrace module and into the loop, which was then kept at room temperature for 5 min. [11C]5 was isolated with reversed phase HPLC on a Luna C18 column (10 × 250 mm, 10 μm; Phenomenex) eluted isocratically with MeCN−10 mM aq HCOONH4 (45:55 v/v) at 6 mL/min (tR = 14 min) (see the Supporting Information). After removal of mobile phase, [11C]5 was formulated for intravenous injection in sterile ethanol-saline (10:90 v/v), and sterile-filtered (Millex-MP 0.22 μm, 25 mm; Merck Millipore; Burlington, MA). The identity of the [11C]5 was confirmed with reversed phase HPLC on a Luna C18 column (4.6 mm × 250 mm, 10 μm; Phenomenex) eluted isocratically with MeCN−10 mM aq HCOONH4 (55:45 v/v) at 2 mL/min (tR = 5.4 min) (see the Supporting Information), and by LC-MS (ESI) (method 1) of associated carrier [tR = 4.80 min, (m/z) [M + H]+: 312.4]. [11C] S was obtained in 20 ± 3% yield from [11C]carbon dioxide in >99% radiochemical purity and with a molar activity of 125 ± 62 GBq/μmol (n = 12).
+ Open protocol
+ Expand
4

Radiosynthesis of [11C]Compound 20

Check if the same lab product or an alternative is used in the 5 most similar protocols
[11C]Iodomethane was trapped in a crimp-sealed V-vial containing 19 (0.7 mg, 1.9 μmol) and solid KOH (5 mg) in DMSO (0.4 mL) and heated at 70°C for 3 min. [11C]20 was isolated with reversed phase HPLC on a Luna C18 column (10 × 250 mm, 10 μm; Phenomenex) eluted isocratically with MeCN−100 mM aq HCOONH4 (65:35 v/v) at 6 mL/min (tR = 9.5 min) (see the Supporting Information). After removal of mobile phase, [11C]20 was formulated for intravenous injection in sterile ethanol-saline (10:90 v/v) containing Tween 80 (12 mg) and sterile-filtered (Millex-MP 0.22 μm, 25 mm). The identity of [11C]20 was confirmed with reversed phase HPLC on a Luna C18 column (4.6 mm × 250 mm, 10 μm; Phenomenex) eluted isocratically with MeCN−100 mM aq HCOONH4 (65:35 v/v) at 2 mL/min (tR = 6.1 min) (see the Supporting Information), and with LC-MS (ESI) (method 2) of associated carrier [tR = 5.31 min, (m/z) [M + H]+: 380.1]. [11C]20 was obtained in 9.8 ± 3.5% yield from [11C]carbon dioxide with >99% radiochemical purity and with a molar activity of 176 ± 73 GBq/μmol (n = 100).
+ Open protocol
+ Expand
5

Analytical and Preparative RP-HPLC of Peptides

Check if the same lab product or an alternative is used in the 5 most similar protocols
Analytical RP‐HPLC was performed on a LC‐20AD instrument (Shimadzu, Japan) equipped with a Luna C18 column (4.6 × 50 mm, 3 µm; Phenomenex, USA) using 5–60% linear gradients of solvent B (0.036% TFA in MeCN) into A (0.045% TFA in H2O) at a flow rate of 1 ml/min and UV detection at 220 nm. For more polar peptides 2 (GSSQSSGSGSSQSSG) and 6 (GSSRSSGSGSSRSSG) (Table 1), a linear 0–40% B gradient was used. Preparative RP‐HPLC was performed on an LC‐8 instrument (Shimadzu) fitted with a Luna C18 column (21.2 × 250 mm, 10 µm; Phenomenex) using linear gradients of solvent B (0.1% TFA in MeCN) into A (0.1% TFA in H2O) with a flow rate of 25 ml/min and UV detection at 220 nm. LC‐MS was performed in an LC‐MS 2010EV instrument (Shimadzu) fitted with an XBridge C18 column (4.6 × 150 mm, 3.5 µm; Waters, Spain), eluting with linear gradients of 0.08% formic acid in MeCN into 0.1% formic acid in H2O over 15 min at 1 ml/min. Electrospray ionization was performed with a detector voltage of 1.5 kV, in the positive mode, with a nebulizing gas flow of 1.5 L/min, a 1 sec event time and a scan speed of 2000, in the 100–2000 m/z mass range.
+ Open protocol
+ Expand
6

Analytical HPLC of Ferula Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Analytical HPLC analyses were performed on a Shimadzu 10A model HPLC system (Shimadzu Analytical and Measuring Instruments, Kyoto, Japan) with a pump (LC-10AD), a diode-array detector (DAD) (SPD-M10A), and an autosampler (SIL-10AD). A Luna C18 column (250 × 4.60 mm, 5 micron; Phenomenex, Torrance, CA, USA) was used for the comparison of the dichloromethane extract of Ferula huber-morathii with reference compounds ferutinin (17) and elaeochytrin A (18) (isolated from Ferula elaeochytris Korovin) and cytotoxic sesquiterpene coumarin ethers of F. huber-morathii (i.e., compounds 115) (Supplementary Materials Figure S40).
A Gilson PLC 2050 (Saint-Avé, France) preparative HPLC system with a Luna C18 column (150 × 21.2 mm, 5 micron; Phenomenex, Torrance, CA, USA) was used for the preparative HPLC purifications.
Supelco Silica gel 60 F254 PTLC plates (0.5, 1, and 2 mm; Merck, Darmstadt, Germany) were used for the preparative separations. Silica gel 60 F254 TLC plates (0.25 mm; Merck, Darmstadt, Germany) were used for the analytical separations. A UV lamp (Camag, Muttenz, Switzerland) with 254 and 366 nm wavelength detection capabilities was used for the visualization of plates. Compounds without chromophore groups were detected by spraying plates with freshly prepared 10% p-anisaldehyde in 10% ethanolic sulfuric acid, followed by heating.
+ Open protocol
+ Expand
7

Isolation and Identification of Citrus Pathogens

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ramulus cinnamomi (RC) were bought in June 2013 from Zhangshu medicinal market, Jiangxi Province, China, and authenticated by Prof Shouran Zhou (College of Basic Medicine, Jiangxi University of Traditional Chinese Medicine). A voucher specimen (no. RC-201306) was deposited in the herbarium of Jiangxi Key Laboratory for Postharvest Technology and Nondestructive Testing of Fruits & Vegetables, Jiangxi Agricultural University (Jiangxi, China).
Penicillium italicum, Penicillium digitatum, Geotrichum candidum Link, Colletotrichum gloeosporioides (Penz.), Alternaria citri, and Phytophthora spp. were provided by the Jiangxi Key Laboratory for Postharvest Technology and Nondestructive Testing of Fruits & Vegetables (Nanchang, China). All the test strains were preserved on potato dextrose agar.
1H- and 13C-NMR spectral data were tested on a Varian 400 MHz Nuclear magnetic resonance spectrometer. HPLC was conducted on a Hitachi Elite 2100 system, Luna C18 column (5 µm, 4.6 mm × 250 mm) for analysis and Luna C18 column (5 µm, 10 mm × 250 mm) for semi-preparative HPLC were purchased from Phenomenex Inc. The HPLC grade solvents were purchased from Sigma (Sigma, USA). All analytical solvents were bought from Tansoole (Shanghai, China).
+ Open protocol
+ Expand
8

Peptide Purification by RP-HPLC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peptides were analyzed and purified using RP-HPLC. 0.1% TFA in deionized (d.i.) water and 80% ACN, 0.1% TFA in d.i. water were used as eluent A and eluent B, respectively.
Analytical HPLC experiments were performed on a Hewlett-Packard Agilent 1100 Series HPLC apparatus using a Luna C18 column (100 Å, 5 μm, 250 × 4.60 mm, Phenomenex, Aschaffenburg, Germany), at a flow rate of 1.2 mL∙min−1 with a gradient of 0 to 25% B over 25 min.
Preparative chromatography was carried out on a Shimadzu HPLC instrument equipped with a Luna C18 column (100 Å, 10 μm, 250 × 21.2 mm, Phenomenex, Aschaffenburg, Germany) at a flow rate of 4 mL∙min−1. The gradient was 0 to 30% B over 60 min for P33, 30% to 60% B over 100 min for Fe65-WW, 20% to 60% B over 120 min for Pin1-WW, and 0 to 40% B over 80 min for PPPPP.
+ Open protocol
+ Expand
9

Quantitative HPLC Analysis of Caffeoylquinic Acids and Anthocyanins

Check if the same lab product or an alternative is used in the 5 most similar protocols
LF was dispersed in 50% EtOH (10 mg/mL) by vortex mixer. Dispersed solutions were sonicated for 10 min and centrifuged. The supernatant was used for HPLC analysis. AM was dissolved in 70% EtOH (5 mg/mL) and directly used for HPLC analysis. All samples were filtered using 0.45 μm nylon syringe filter before injecting it into the HPLC system.
Chromatographic separations of caffeoylquinic acids (CQAs) were achieved using a Phenomenex Luna C18 column (250 mm × 4.6 mm I.D, 100 Å). A reverse phase HPLC was carried out by gradient conditions, and the flow rate of mobile phase was 1.0 mL/min. Mobile phases were composed in 0.1% triflouroacetic acid (TFA) in deionized water (A) and methanol (B). The gradient program started in 15% B and with the following composition: 0–3 min, 15% B; 3–7 min, 19% B; 7–15 min, 19% B; 15–28 min, 32% B; 28–33 min, 90% B; 33–38, 15% B; and 38–43, 15% B. Column oven was set at 30°C, and the detection of CQAs was performed at 330 nm on a UV detector.
C3G was determined by separating with a Phenomenex Luna C18 column (150 mm × 4.6 mm, 100 Å), and the mobile phases were composed of 0.4% of TFA in deionized water and 0.4% of TFA in 50% MeOH. The gradient program begun in 0% B: 0–2 min, 70%; 20–22 min, 100%, 22–30 min, 0% B; 30–35 min, 0% B. Temperature of separation was set at 30°C, and the detection wavelength was 520 nm.
+ Open protocol
+ Expand
10

Roseobactin Purification from P. inhibens

Check if the same lab product or an alternative is used in the 5 most similar protocols
P. inhibens 2.10 was grown in 5 mL ½YTSS at 30°C/250 rpm overnight. The overnight culture was diluted into 15 mL ½YTSS medium in a 125 mL flask and grown at 30°C/160 rpm for 20 hr before diluting into large cultures. Large cultures (6 × 800 mL in 4 L flask) of P. inhibens 2.10 were grown in ½YTSS supplemented with 100 μM EDTA and 1 mM pCA, starting with an initial OD600 nm of 0.05 at 30°C/160 rpm. After 2 days, at which point roseobactin production was optimal, the large cultures were spun down and the supernatant filtered prior to application to an Oasis HLB column (1 g sorbent, 20 mL syringe), which had been washed with 10 CV of MeOH and equilibrated with 10 CV of H2O. The HLB column was washed with 50 mL of 5% MeOH, and then eluted stepwise with 25 mL each of 20%, 40%, 70%, and 100% MeOH plus 0.2% FA. The 20% fraction, which contained roseobactin, was dried down in vacuo and subsequently separated by preparative HPLC using a Phenomenex Luna C18 column (5 μm, 21.2 × 250 mm) with a gradient of 5–59% MeCN in H2O + 0.1% FA over 21 min. The fractions containing roseobactin were combined and dried in vacuo. A second separation on semi-preparative HPLC using a Phenomenex Luna C18 column (5 μm, 10 × 250 mm) with an isocratic gradient of 7% MeCN in H2O (+0.1% FA) delivered pure roseobactin.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!